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Motor proteins: A dynamic duo
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The interactions between the microtubule motor
cytoplasmic dynein and its putative regulator dynactin
have been shown to be dynamic and complex.
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Eukaryotic microtubule-based motors drive a wide range
of complex and vital movements during both interphase
and metaphase of the cell cycle. This motility must be
under strict temporal and spatial control so that the right
movement occurs only at the right time, and in the correct
direction. Our understanding of the regulation of one
microtubule motor — cytoplasmic dynein — has increased
considerably because of recent work on an additional
regulatory complex named dynactin.
Both cytoplasmic dynein and dynactin are very large
polypeptide complexes (Fig. 1). Dynactin was originally
identified because it activated the movement of salt-
washed vesicles in the presence of purified cytoplasmic
dynein, which, surprisingly, did not promote vesicle motil-
ity on its own [1,2]. There is considerable genetic evi-
dence from fungi, yeast and flies that both cytoplasmic
dynein and dynactin are required for movements involved
in nuclear migration, spindle and nuclear positioning, and
for neuronal development (see [3] and references therein).
Cell biology and biochemistry are now catching up, and
are providing new information on how the two complexes
interact [4–8].
Given that dynactin was first identified as an activator of
vesicle movement in vitro [1,2], it is surprising that it has
taken so long to come up with direct evidence for this role
in a more complex experimental system. In one approach,
antibodies to the p150Glued component of dynactin were
added to squid axoplasm, resulting in slowing and stop-
ping of vesicle movement along microtubules (see Fig. 2;
C.M. Waterman-Storer, D.G. Weiss, G.M. Langford,
S.Kuznetsov and E.L.F. Holzbaur, personal communica-
tion). Interestingly, although cytoplasmic dynein moves
only towards the minus, or slow-growing, ends of micro-
tubules, the anti-p150Glued antibodies inhibited movement
in both directions, implying there may be some interplay
between dynein and the plus-end-directed motor kinesin
(see below). Further evidence that cytoplasmic dynein
and dynactin function together to promote membrane
movement comes from Echeverri et al. [7], who found that
over-expressing one component of dynactin — p50, or
dynamitin — in cultured cells resulted in the fragmenta-
tion of the Golgi apparatus and changed the position of
endosomes and lysosomes. All of these organelles have
long been thought to move using dynein, an assumption
based on their direction of movement and on dynein local-
ization studies (reviewed in [9]). We await with interest a
full report of the effects of p50 over-expression on
organelle movement.
Over-expression of p50 has other serious consequences for
the cell, indicating the importance of dynein–dynactin
during metaphase. Both complexes are localized to the
kinetochore at prometaphase [7], which is consistent with
their involvement in moving chromosomes towards the
spindle poles during the initial stages of spindle morpho-
genesis. In cells over-expressing p50, both dynactin and
dynein are lost from the kinetochores and the chromo-
somes fail to align properly. Prometaphase cells accumu-
late, and the spindles themselves are distorted, although
still bipolar. In contrast, when antibodies against cytoplas-
mic dynein are micro-injected into cells, monopolar spin-
dles are formed [10], suggesting dynein is also involved in
generating tension between the spindle poles and the cell
cortex [7,10]. How does the presence of excess amounts of
one dynactin component have such catastrophic effects on
the function of dynactin? The answer may lie in the struc-
tural dynamics of the dynactin complex, and its interaction
with cytoplasmic dynein.
The intermediate chains of cytoplasmic and axonemal
dyneins share sequence homology in their carboxy-termi-
nal halves, and they are thought to target dynein to its
cargo (reviewed in [11]). In the case of axonemal dyneins,
that means anchoring dynein to the microtubule. Interest-
ingly, affinity chromatography and blot overlay approaches
have shown that cytoplasmic dynein intermediate chains
interact with the p150Glued component of dynactin. The
binding site has been mapped to amino acids 200–811 of
p150Glued [4–6,8] (Fig. 1c), and amino acids 1–123 of the
dynein intermediate chain [5]. The p150Glued molecule
also interacts with the Arp-1 (actin-related protein) fila-
ment, via a carboxy-terminal charged domain (1005–1019;
[6]), and with microtubules, both in vitro [5,6] and in vivo
[6], via its amino-terminus (39–150). The p150Glued com-
ponent therefore forms the multivalent centre of the dyn-
actin complex. One caveat, however, is that because of
the complexity of the structures involved, all these studies
have used in vitro-translated, bacterially expressed or over-
expressed individual polypeptides to provide one side of
each interaction. Whether this provides a true measure of
the dynein–dynactin interaction in vivo remains to be
confirmed.
What is clear, however, is that dynactin can be broken up
in a number of ways, with severe consequences for dynein
function. For instance, over-expression of p50 causes the
dynactin complex to disassemble, apparently without
affecting dynein structure ([7]; Fig. 2); dynein then seems
to be unable to find its target correctly. Although the
location of the five p50 molecules within the dynactin
complex is unknown, it is tempting to speculate that they
form the shoulder between the p150Glued stalk and the
Arp-1 filament (Fig. 2; [12]). If this were the case, then it
is easy to imagine that disturbing p50/dynamitin
interactions would blow the dynactin complex apart.
Dynactin structure is also compromized in Drosophila that
are heterozygous for the Glued mutation, in which a
p150Glued protein lacking about 300 amino acids from the
carboxyl terminus is expressed as well as the wild-type
protein. The truncated protein is not incorporated into the
dynactin complex, but can still bind to microtubules and
still co-localizes with cytoplasmic dynein in embryos [3].
This is thought to be a ‘poison product’, which then
interferes with normal dynein–dynactin function in het-
erozygotes. Interestingly, various mutant forms of cyto-
plasmic dynein heavy chain can act as suppressors or
enhancers of the mutant Glued phenotype [3], suggesting
that the heavy chains themselves have some part to play in
the dynein–dynactin interaction, although perhaps an
indirect one.
So what is dynactin doing, and how does it activate dynein
function? These questions are unanswered as yet, but
several models have been proposed. First, dynactin may,
by virtue of the ability of p150Glued to bind to micro-
tubules, serve to tether the cargo to the microtubule while
the dynein heads are released during the ATPase cycle
[6]. A second possibility is that dynactin may activate
dynein’s ATPase activity directly [11]. A third possibility
is that dynactin forms part of the machinery that targets
dynein to its correct location, either as an integral part of a
dynein ‘receptor’, or by serving in a cyclical fashion to load
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Heavy chain: 2 x ~530 kD; 2 or 3 genes [13,18].
Intermediate chain: 3 x ~74 kD; 2 genes, 
5 mRNAs (including a neuronal-specific form [19]), 
multiple phospho-isoforms [5,19].
Light intermediate chain: several 53–59 kD; 
2 genes, possible alternative splicing, multiple 
phospho-isoforms [16,17].
Light chain: 8kD (and possibly 11 kD) [20]. 

Dynactin
p150Glued: 2 x 135–160 kD; 1 gene, 
1–3 mRNAs, up to 3 different molecular 
weights [2,3,8,12].
p62: 1 x 62 kD; uncharacterized [2,12].
p50/dynamitin: 5 x 50 kD; single gene, 1 major 
mRNA [7].
Actin-related protein 1 (Arp-1)/centractin: 
9 x 45 kD; 2 genes encoding α and β (and
possibly γ) forms at 15:1 ratio in the 
complex [12,21].
Actin: 1 x 45 kD [2,20].
Capping protein: 1 x 37 kD, 1 x 32 kD; α and β 
isoforms, respectively [12].
p24 and p27: 1 each; not yet characterized [12].
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(a) Summary of the polypeptide composition of cytoplasmic dynein
and dynactin. (b) Model of the dynactin complex (based on data from
[12]) and its proposed interaction with microtubules and cytoplasmic
dynein. p50 is drawn at the base of p150, where it could interact with
both p150Glued and the Arp-1 filament, although this has not been
shown directly. As it is not clear how dynactin interacts with the cargo
surface, this is left undefined. (c) Summary of proposed p150Glued
functional domains [4–6,8].
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dynein onto its cargo (for example, [11]). How, and indeed
whether, such interactions take place remains to be deter-
mined, but it has been suggested that dynactin may asso-
ciate with membranes via the kinesin receptor kinectin, or
that it may bind via the Arp-1 filament to a fibrous
‘skeleton’ on the membrane or kinetochore surface [11].
Whichever of these models is correct, there are still
several outstanding conundrums. One concerns the speci-
ficity of the targeting mechanism, as dynein can clearly
function in many different places. So far, we have treated
all cytoplasmic dynein and dynactin molecules as being
identical, but different combinations of polypeptides
could obviously be generated by alternative splicing, post-
translational modification, or the transcription of some
subunits from alternative genes (Fig. 1). Indeed, prelimi-
nary evidence suggests that one cytoplasmic dynein heavy
chain isoform may be localized preferentially to the Golgi
complex [13], and the 150 kD and 135 kD forms of
p150Glued have been shown to behave differently in a
number of in vitro assays [4,8].
The second conundrum concerns regulation of the com-
plex. For instance, the fact that p150Glued can itself bind to
microtubules seems counterintuitive, as it might be exp-
ected to impede the movement of dynein, unless it bound
microtubules with a low affinity [4]. If dynactin only tran-
siently guides dynein to its cargo, however, this may not be
a problem. Alternatively, perhaps the binding of p150Glued
is co-ordinated with dynein’s ATPase cycle. Although the
microtubule binding of a related endosome-associated
protein, CLIP-170 [14], is regulated by phosphorylation, it
is not clear whether this is true for p150Glued and, indeed,
the extent to which ATP can release p150Glued or dynactin
from microtubules varies between experimental systems
[2,3,6,8].
As many structures, including organelles and kinetochores,
can switch between movement towards the minus end and
the plus end, the idea that kinesin and dynein–dynactin
may share some components of the targeting machinery —
which would imply some type of reciprocal regulation — is
an attractive one [11]. Recent work on the regulation of
organelle movement during the cell cycle using Xenopus
egg extracts, however, has revealed that, although both
directions of movement are inhibited in metaphase, the
control of minus-end-directed movement is brought about
by releasing both dynein and dynactin from the membrane
(Fig. 2), whereas the binding of kinesin to membranes is
unaffected [15]. In this situation, at least, the motors are
behaving independently.
This regulated release of both dynein and dynactin from
the membrane in metaphase extracts has an obvious
parallel with the loss of both components from kinetochores
at the metaphase plate in cells [7]. Interestingly, the
Figure 2
Schematic representation of the regulation of dynein–dynactin
interactions under various conditions. Components are shown in
shaded boxes when it is not known how the conditions affect their
composition. Only the Arp-1 filament, p150Glued, p50 and cytoplasmic
dynein are shown, as data are not available for any other components. 
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inhibition of motility and release of dynein from
membranes correlates with the hyperphosphorylation of
dynein light intermediate chains, whose role in the function
of dynein–dynactin is unclear [15]. There is no evidence so
far that the light intermediate chains interact with any dyn-
actin components [5]. As the light intermediate chains
contain putative ATP-binding sites, it has been suggested
that they might regulate the dynein ATPase directly
[16,17]. Soluble dynein remains active in metaphase
extracts, however, so light-intermediate-chain phosphoryla-
tion does not switch off motor activity in this case [15].
These results emphasize the fact that there are a number of
components in both dynein and dynactin whose functions
have yet to be established, and which should not be
ignored. As always, the more information we obtain, the
more questions are raised. The dynein–dynactin interaction
looks set to keep us occupied for many years to come.
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